Alan F. Holmer's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 16,000 Stock options (right to buy) done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 16,000 | 16,000 | - | - | Stock options (right to buy) | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 4,800 | 10,629 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 1,667 | 0 | - | - | Options to purchase common stock | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.00 per share. | 14 Jun 2024 | 1,667 | 5,829 (0%) | 0% | 30 | 50,010 | Common Stock, par value $0.0001 per share |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 2,783 | 4,162 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 2,783 | 2,783 | - | - | Stock Option (right to buy) | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.97 per share. | 26 Jan 2024 | 629 | 1,379 (0%) | 0% | 5.0 | 3,126 | Common Stock |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 629 | 0 | - | - | Options to purchase common stock | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 79,600 | 79,600 | - | - | Stock Option(right to buy) | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 58,200 | 58,200 | - | - | Stock Option (right to buy) | |
| Corbus Pharmaceuticals | Alan F. Holmer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 58,200 | 58,200 | - | - | Stock Option (right to buy) |